UiPath (NYSE:PATH) Stock: Insider Raghavendra Malpani Sells 29,564 Shares

UiPath, Inc. (NYSE:PATH – Get Free Report) insider Raghavendra Malpani sold 29,564 shares of the company’s stock in a transaction dated Friday, October 9th. The stock was sold at an average price of $13.51, for a total transaction of $399,409.64. Following the transaction, the insider owned 1,514,281 shares in the company, valued at approximately $20,457,936.31. This trade represents a 1.91% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Raghavendra Malpani also recently made the following trade(s):

  • On Thursday, September 17th, Raghavendra Malpani sold 40,464 shares of UiPath stock. The stock was sold at an average price of $14.00, for a total transaction of $566,496.00.

UiPath Stock Down 1.5%

Shares of NYSE:PATH opened at $13.05 on Thursday. The firm has a market cap of $6.80 billion, a P/E ratio of 19.49, a P/E/G ratio of 1.24 and a beta of 1.01. UiPath, Inc. has a 12 month low of $9.20 and a 12 month high of $19.84. The company’s 50-day moving average price is $14.75 and its two-hundred day moving average price is $12.36.

UiPath (NYSE:PATH – Get Free Report) last announced its earnings results on Thursday, September 3rd. The company reported $0.15 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.15. UiPath had a net margin of 21.03% and a return on equity of 9.70%. The company had revenue of $410.26 million during the quarter, compared to the consensus estimate of $397.77 million. During the same period in the previous year, the firm posted $0.15 earnings per share. The company’s revenue was up 13.3% on a year-over-year basis. As a group, equities analysts predict that UiPath, Inc. will post 0.49 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Pasadena Private Wealth LLC boosted its position in shares of UiPath by 9.0% in the 1st quarter. Pasadena Private Wealth LLC now owns 12,750 shares of the company’s stock worth $142,000 after purchasing an additional 1,050 shares during the last quarter. CoreCap Advisors LLC increased its holdings in UiPath by 68.7% in the third quarter. CoreCap Advisors LLC now owns 2,679 shares of the company’s stock valued at $34,000 after purchasing an additional 1,091 shares during the last quarter. Allworth Financial LP increased its holdings in UiPath by 5.2% in the second quarter. Allworth Financial LP now owns 23,537 shares of the company’s stock valued at $256,000 after purchasing an additional 1,160 shares during the last quarter. Corient Private Wealth LLC increased its holdings in UiPath by 5.6% in the fourth quarter. Corient Private Wealth LLC now owns 27,283 shares of the company’s stock valued at $447,000 after purchasing an additional 1,455 shares during the last quarter. Finally, Wedbush Securities Inc. lifted its stake in UiPath by 14.0% in the second quarter. Wedbush Securities Inc. now owns 11,920 shares of the company’s stock valued at $130,000 after buying an additional 1,465 shares during the period. Institutional investors own 62.50% of the company’s stock.

Key Stories Impacting UiPath

Here are the key news stories impacting UiPath this week:

  • Positive Sentiment: UiPath’s stock has gained 33% over six months, supported by increased enterprise AI adoption, positive fiscal 2026 net income and improving profitability. Analysts view the company’s valuation as relatively attractive compared with its growth prospects. UiPath Stock Gains 33% in 6 Months
  • Positive Sentiment: UiPath continues to generate higher absolute revenue than Figma and is scaling its AI-powered automation platform for global enterprises. Its latest reported quarter also showed 13.3% year-over-year revenue growth and revenue above analyst expectations. C3.ai vs. UiPath
  • Neutral Sentiment: Analyst sentiment remains mixed: the consensus rating is “Hold,” with an average price target of $15.69, while individual targets range from $14 to $22. This suggests potential upside but limited conviction across Wall Street.
  • Neutral Sentiment: Executive commentary about AI agents, workforce effects and “AI slop” provides industry context but does not represent a new financial catalyst for UiPath. UiPath’s Michael Atalla on AI Agents
  • Negative Sentiment: Two insiders sold a combined 56,968 shares worth approximately $773,000. Brad Brubaker reduced his position by 2.51%, while Raghavendra Malpani reduced his by 1.91%; both retained substantial holdings, limiting the severity of the signal but potentially adding selling pressure. Brad Brubaker SEC Filing Raghavendra Malpani SEC Filing
  • Negative Sentiment: Revenue growth comparisons show UiPath’s performance has been volatile, with seasonal spikes followed by declines, while Figma has posted consistent quarter-over-quarter growth and is narrowing the revenue gap. This raises concerns about the durability and consistency of UiPath’s growth profile. Figma vs. UiPath Revenue Growth Trends

Wall Street Analyst Weigh In

Several research firms recently weighed in on PATH. KeyCorp restated a “sector weight” rating on shares of UiPath in a research report on Thursday, September 24th. Mizuho increased their price objective on UiPath from $12.00 to $14.00 and gave the company a “neutral” rating in a research report on Friday, September 4th. Royal Bank Of Canada reissued an “outperform” rating on shares of UiPath in a research note on Wednesday, September 23rd. DA Davidson reissued an “underperform” rating and issued a $10.00 target price on shares of UiPath in a research note on Monday, September 28th. Finally, Oppenheimer restated a “market perform” rating on shares of UiPath in a research report on Friday, September 4th. Four investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $15.69.

Get Our Latest Stock Analysis on PATH

About UiPath

(Get Free Report)

UiPath, Inc is a software company that develops an enterprise automation platform designed to help organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation, artificial intelligence, workflow orchestration, process mining, document processing and application integration tools to support automation across departments and business systems.

UiPath offers products and services for discovering automation opportunities, building and managing software robots, processing documents and other unstructured data, and governing automation programs at scale.

See Also

Insider Buying and Selling by Quarter for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.